Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hemangiosarcoma × Surveys and Questionnaires × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 56 Neoplasms 26 Prostatic Neoplasms 22 Lung Neoplasms 18 Head and Neck Neoplasms 15 Neoplasm Metastasis 14 Colorectal Neoplasms 14 Multiple Myeloma 12 Gastrointestinal Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Motor Activity 9 Fatigue 9 cyclopia sequence 8 Uterine Cervical Neoplasms 8 Ovarian Neoplasms 8 Pain 7 Lymphoma 7 Esophageal Neoplasms 7 Recurrence 6 Oropharyngeal Neoplasms 6 Neoplasms, Plasma Cell 6 Endometrial Neoplasms 6 Anxiety Disorders 6 Tobacco Use Cessation 5 Smoking Cessation 5 Rectal Neoplasms 5 Pancreatic Neoplasms 5 Leukemia 5 Hematologic Neoplasms 5 Depression 5

Interventions

Doxorubicin 15 Ifosfamide 9 pazopanib 6 Paclitaxel 6 pembrolizumab 4 Radiotherapy 4 Gemcitabine 4 Filgrastim 4 spartalizumab 3 durvalumab 3 Sorafenib 3 Propranolol 3 Nivolumab 3 Ipilimumab 3 Docetaxel 3 trebananib 2 cixutumumab 2 carotuximab 2 brostallicin 2 belinostat 2 balstilimab 2 Trabectedin 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Conformal 2 Magnetic Resonance Spectroscopy 2 Imatinib Mesylate 2 Epirubicin 2 Carboplatin 2 Bevacizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01786889 2016-07-29

ANGIHE

Centre Oscar Lambret

Phase NA Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡